PCV51 COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK

Abstract

Authors

M.R. Cowie A. Lamy P. Levy S. Mealing A. Millier P. Mernagh O. Cristeau J.B. Briere K. Bowrin

Full Text Cite This Article
Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×